Skip to main content

5 Result(s)

within A Balcerska Remove this filter

and

  1. No Access

    Chapter

    First-Line Immunosuppressive Treatment in Children with Aplastic Anemia: Rabbit Antithymocyte Globulin

    Immunosuppressive therapy is the treatment of choice in children with acquired severe aplastic anemia (AA) and no HLA-matched family donor. The paper presents results of a multicenter study of 63 children with...

    K. Pawelec, M. Salamonowicz, A. Panasiuk… in Respiratory Virology and Immunogenicity (2015)

  2. No Access

    Article

    Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2 versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group

    PURPOSE: A non objective randomised, retrospective study was performed to assess and compare the efficacy of two different high doses of methotrexate (HD-MTX) in combination with intrathecal therapy in childre...

    K. Derwich, J. Wachowiak, O. Zając-Spychała… in memo - Magazine of European Medical Oncolo… (2011)

  3. No Access

    Article

    ß Thalassemia a surprising reason for anaemia in North Poland children

    B. Kaczorowska-Hac, A. Balcerska in Annals of Hematology (2008)

  4. No Access

    Article

    Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia

    Until 1983, results of treatment of acute myelogenous leukemia (AML) in Poland with different regimens were very poor. In 1983, the Polish Pediatric Leukemia/Lymphoma Study Group introduced a unified treatment...

    A Dluzniewska, W Balwierz, J Armata, A Balcerska, A Chybicka, J Kowalczyk… in Leukemia (2005)

  5. No Access

    Chapter and Conference Paper

    Results of Stem Cell Transplantation in Children with CML in Comparison with Treatment with Cytostatics alone or with Interferon alfa. Report of the Polish Children’s Leukemia/ Lymphoma Study Group

    Philadelphia positive chronic myeloid leukemia (CML Ph+) is a malignant clonal hematological disease of pluripotent stem cell representing 2–5% of all childhood leukemias [2]. The incidence of CML increases with ...

    A. Chybicka, K. Kalwak… in Transplantation in Hematology and Oncology… (2003)